126-50-1 Usage
Uses
Used in Pharmaceutical Industry:
4-acetyl-4-(2-cyanoethyl)heptanedinitrile is used as a key intermediate for the synthesis of various pharmaceuticals, owing to its ability to undergo multiple chemical reactions to produce a wide range of useful products. Its high reactivity and stability contribute to the development of novel drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4-acetyl-4-(2-cyanoethyl)heptanedinitrile serves as an essential building block for the creation of new agrochemicals. Its versatile nature allows for the synthesis of compounds with potential applications in crop protection, pest control, and other agricultural areas, enhancing the efficiency and effectiveness of these products.
Used in Organic Synthesis:
4-acetyl-4-(2-cyanoethyl)heptanedinitrile is utilized as a valuable component in organic synthesis due to its capacity to participate in various chemical reactions. This enables the production of a diverse array of organic compounds with applications in different industries, such as the synthesis of specialty chemicals, dyes, and other organic materials.
Used in Chemical Research:
The high reactivity and stability of 4-acetyl-4-(2-cyanoethyl)heptanedinitrile make it an attractive candidate for chemical research. It is employed in the exploration of new synthetic pathways, the development of novel chemical reactions, and the study of reaction mechanisms, contributing to the advancement of chemical science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 126-50-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126-50:
(5*1)+(4*2)+(3*6)+(2*5)+(1*0)=41
41 % 10 = 1
So 126-50-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N3O/c1-11(16)12(5-2-8-13,6-3-9-14)7-4-10-15/h2-7H2,1H3
126-50-1Relevant academic research and scientific papers
COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
-
Page/Page column 96, (2014/03/25)
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.
